Federal Cannabis Policy: DOJ’s move to reclassify medical marijuana from Schedule I to Schedule III could unlock new federal tax benefits and ease compliance for medical operators, while recreational cannabis still faces a tougher federal status and an upcoming DEA hearing may shape what comes next. Hemp Crackdown Fight: GOP lawmakers filed amendments to block or delay federal recriminalization of hemp THC products this year, arguing for revised definitions, labeling, and enforcement limits. Safety & Compliance: A Johns Hopkins study warns that edible cannabis plus alcohol can impair driving more than either alone, and standard field sobriety tests may miss it—raising pressure for better public guidance and detection. State Retail Spotlight: Minnesota’s first regulated cannabis retail opening in Stillwater highlights a shift toward licensed sourcing and customer education over gray-market products. Tech in the Cannabis Orbit: Cannabix expanded BreathLogix alcohol screening into mining, municipal, and aviation in Australia, signaling continued crossover of cannabis-adjacent tech into workplace safety. Legal/Industry Risk: MMJ International Holdings filed a formal challenge to DEA marijuana rescheduling, raising constitutional and regulatory questions about how compliant companies are treated. Research Watch: Multiple reports this week continued to link cannabis use with specific health and risk concerns, including driving impairment and other medical outcomes.